We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

Structured Walking Protocol Boosts Post-Stroke Recovery: Insights from the Walk ‘n Watch Trial

MedXY Editorial Team•Dec 23, 2025•Neurology
clinical trialsneuroplasticityphysical therapystroke rehabilitation

Highlights

  • The Walk ‘n Watch trial demonstrated a 43.6-meter greater improvement in the 6-minute walk test (6MWT) compared to usual care.
  • The structured, progressive protocol was delivered safely by front-line physical therapists with no serious adverse events during exercise sessions.
  • Pragmatic implementation at 12 sites across Canada suggests the protocol is feasible for real-world inpatient stroke rehabilitation.
  • The intervention addresses the repetition gap by mandating at least 30 minutes of high-intensity walking per session.

Introduction: Addressing the Repetition Gap in Stroke Recovery

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 TrialsPhase 3 trials show satralizumab significantly improves proptosis, inflammation, and diplopia in thyroid eye disease with a favorable safety profile, marking a new therapeutic option targeting the IL-6 receptor pathway.Sep 12, 2026Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Insights from ACACIA-HCM and Complementary TrialsAficamten, a cardiac myosin inhibitor, demonstrated significant improvements in symptoms, diastolic function, and biomarkers in nonobstructive hypertrophic cardiomyopathy across multiple trials, including the pivotal ACACIA-HCM study.Sep 6, 2026Defining and Achieving Disease Stability in COPD: Insights from Phase 3 TrialsThis article explores disease stability as a key treatment target in COPD, analyzing major phase 3 trials that show stability predicts reduced exacerbations and mortality, supporting its use to guide therapy.Sep 9, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts
Drug-Induced Liver Injury (DILI) remains a pivotal challenge in drug development, with evolving drug modalities and clinical trial designs prompting updated regulatory perspectives from FDA specialists.
Sep 7, 2026
Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groupsThis review contrasts early- and late-phase gynecologic oncology trials, underscoring disparities in trial completion, publication, and racial/ethnic minority enrollment, highlighting the need to improve inclusivity and reporting.Aug 22, 2026
Enhancing Patient Engagement in Gynecologic Oncology Clinical Trials Through a Pilot Patient Ambassador ProgramA pilot program using former gynecologic oncology trial participants as patient ambassadors improved confidence and perceptions about clinical trials among trial-naïve patients, highlighting a feasible peer-education approach.Aug 21, 2026